656 related articles for article (PubMed ID: 24299662)
1. Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial.
Mielgo-Ayuso J; Barrenechea L; Alcorta P; Larrarte E; Margareto J; Labayen I
Br J Nutr; 2014 Apr; 111(7):1263-71. PubMed ID: 24299662
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of high-dose green tea extract on weight reduction: A randomized, double-blind, placebo-controlled clinical trial.
Chen IJ; Liu CY; Chiu JP; Hsu CH
Clin Nutr; 2016 Jun; 35(3):592-9. PubMed ID: 26093535
[TBL] [Abstract][Full Text] [Related]
3. Decaffeinated green tea extract rich in epigallocatechin-3-gallate improves insulin resistance and metabolic profiles in normolipidic diet--but not high-fat diet-fed mice.
Santana A; Santamarina A; Souza G; Mennitti L; Okuda M; Venancio D; Seelaender M; do Nascimento CO; Ribeiro E; Lira F; Oyama L
J Nutr Biochem; 2015 Sep; 26(9):893-902. PubMed ID: 26048201
[TBL] [Abstract][Full Text] [Related]
4. Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet.
Chen N; Bezzina R; Hinch E; Lewandowski PA; Cameron-Smith D; Mathai ML; Jois M; Sinclair AJ; Begg DP; Wark JD; Weisinger HS; Weisinger RS
Nutr Res; 2009 Nov; 29(11):784-93. PubMed ID: 19932867
[TBL] [Abstract][Full Text] [Related]
5. Effects of Nigella sativa oil with a low-calorie diet on cardiometabolic risk factors in obese women: a randomized controlled clinical trial.
Mahdavi R; Namazi N; Alizadeh M; Farajnia S
Food Funct; 2015 Jun; 6(6):2041-8. PubMed ID: 26029855
[TBL] [Abstract][Full Text] [Related]
6. Combined epigallocatechin-3-gallate and resveratrol supplementation for 12 wk increases mitochondrial capacity and fat oxidation, but not insulin sensitivity, in obese humans: a randomized controlled trial.
Most J; Timmers S; Warnke I; Jocken JW; van Boekschoten M; de Groot P; Bendik I; Schrauwen P; Goossens GH; Blaak EE
Am J Clin Nutr; 2016 Jul; 104(1):215-27. PubMed ID: 27194304
[TBL] [Abstract][Full Text] [Related]
7. The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea Trial.
Dostal AM; Samavat H; Bedell S; Torkelson C; Wang R; Swenson K; Le C; Wu AH; Ursin G; Yuan JM; Kurzer MS
Food Chem Toxicol; 2015 Sep; 83():26-35. PubMed ID: 26051348
[TBL] [Abstract][Full Text] [Related]
8. Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice.
Santamarina AB; Carvalho-Silva M; Gomes LM; Okuda MH; Santana AA; Streck EL; Seelaender M; do Nascimento CM; Ribeiro EB; Lira FS; Oyama LM
J Nutr Biochem; 2015 Nov; 26(11):1348-56. PubMed ID: 26300331
[TBL] [Abstract][Full Text] [Related]
9. Green tea catechins prevent low-density lipoprotein oxidation via their accumulation in low-density lipoprotein particles in humans.
Suzuki-Sugihara N; Kishimoto Y; Saita E; Taguchi C; Kobayashi M; Ichitani M; Ukawa Y; Sagesaka YM; Suzuki E; Kondo K
Nutr Res; 2016 Jan; 36(1):16-23. PubMed ID: 26773777
[TBL] [Abstract][Full Text] [Related]
10. Effects of rye bread enriched with green tea extract on weight maintenance and the characteristics of metabolic syndrome following weight loss: a pilot study.
Bajerska J; Mildner-Szkudlarz S; Walkowiak J
J Med Food; 2015 Jun; 18(6):698-705. PubMed ID: 25494205
[TBL] [Abstract][Full Text] [Related]
11. Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects.
Belza A; Frandsen E; Kondrup J
Int J Obes (Lond); 2007 Jan; 31(1):121-30. PubMed ID: 16652130
[TBL] [Abstract][Full Text] [Related]
12. A weight loss diet intervention has a similar beneficial effect on both metabolically abnormal obese and metabolically healthy but obese premenopausal women.
Ruiz JR; Ortega FB; Labayen I
Ann Nutr Metab; 2013; 62(3):223-30. PubMed ID: 23571719
[TBL] [Abstract][Full Text] [Related]
13. Effects of 3-week consumption of green tea extracts on whole-body metabolism during cycling exercise in endurance-trained men.
Eichenberger P; Colombani PC; Mettler S
Int J Vitam Nutr Res; 2009 Jan; 79(1):24-33. PubMed ID: 19839000
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation.
Klaus S; Pültz S; Thöne-Reineke C; Wolfram S
Int J Obes (Lond); 2005 Jun; 29(6):615-23. PubMed ID: 15738931
[TBL] [Abstract][Full Text] [Related]
15. No effect of epigallocatechin-3-gallate with weight loss on adiposity reduction, cardiometabolic risk factors and liver function in pre-menopausal obese women.
Kawada T
Br J Nutr; 2014 Nov; 112(9):1586. PubMed ID: 25247887
[No Abstract] [Full Text] [Related]
16. Normal vs. high-protein weight loss diets in men: effects on body composition and indices of metabolic syndrome.
Tang M; Armstrong CL; Leidy HJ; Campbell WW
Obesity (Silver Spring); 2013 Mar; 21(3):E204-10. PubMed ID: 23592676
[TBL] [Abstract][Full Text] [Related]
17. A pilot study investigating the effect of Caralluma fimbriata extract on the risk factors of metabolic syndrome in overweight and obese subjects: a randomised controlled clinical trial.
Astell KJ; Mathai ML; McAinch AJ; Stathis CG; Su XQ
Complement Ther Med; 2013 Jun; 21(3):180-9. PubMed ID: 23642949
[TBL] [Abstract][Full Text] [Related]
18. Long-term green tea extract supplementation does not affect fat absorption, resting energy expenditure, and body composition in adults.
Janssens PL; Hursel R; Westerterp-Plantenga MS
J Nutr; 2015 May; 145(5):864-70. PubMed ID: 25740906
[TBL] [Abstract][Full Text] [Related]
19. Acute effects of epigallocatechin gallate from green tea on oxidation and tissue incorporation of dietary lipids in mice fed a high-fat diet.
Friedrich M; Petzke KJ; Raederstorff D; Wolfram S; Klaus S
Int J Obes (Lond); 2012 May; 36(5):735-43. PubMed ID: 21750518
[TBL] [Abstract][Full Text] [Related]
20. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
Muls E; Kolanowski J; Scheen A; Van Gaal L;
Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
